We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

CERTEST BIOTEC

Certest Biotec, S.L. develops and manufactures IVD products in the human clinical testing field, including rapid test... read more Featured Products: More products

Download Mobile App





CerTest Showcases Latest Innovations in Diagnosis of Infectious Diseases

By LabMedica International staff writers
Posted on 12 Nov 2024
Print article
Image: Certest is highlighting the new VIASURE V-FLEX system at the world’s largest healthcare exhibition event (Photo courtesy of CerTest)
Image: Certest is highlighting the new VIASURE V-FLEX system at the world’s largest healthcare exhibition event (Photo courtesy of CerTest)

CerTest Biotec (Zaragoza, Spain) is ending the 2024 exhibition calendar with its participation in this year’s MEDICA. With more than 5,300 exhibitors from almost 70 different countries, MEDICA is one of the largest medical B2B exhibitions in the world. CerTest is presenting again at MEDICA this year, highlighting the different medical diagnostic technologies it has developed to over 83,000 visitors expected at the event. At MEDICA 2024, Certest is showcasing the V-Flex system that is part of its VIASURE Complete Solution designed to achieve a better molecular diagnostic workflow. The VIASURE V-FLEX system is a new fully automated solution in molecular biology for nucleic acid extraction, purification, and PCR set-up from biological matrix and samples. The instrument has been designed with flexible configurations to meet different user needs.

Visitors to the Certest booth can also learn about the VIASURE DNA/RNA pathogen extraction kit designed to extract from various biological samples: swabs, saliva, sputum, bronchoalveolar lavages, fecal and urine samples. The kit is based on magnetic particles, which allows its automation for high throughput analysis, reducing hands-on time and improving reproducibility. The extraction kit is currently optimized for two types of magnetic separation methods: VIASURE V-Flex and KingFisher Flex. Certest is also demonstrating the VIASURE V-Smart software that allows the analysis and interpretation of the VIASURE Real-Time PCR assays. VIASURE V-Smart facilitates the conversion of the PCR raw data into test results with minimal manual intervention.

Related Links:
CerTest Biotec

New
Gold Member
Veterinary Hematology Analyzer
Exigo H400
New
Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
snRNP-C Test
Chorus snRNP-C Test
New
Silver Member
CEA Assay
Carcinoembryonic Antigen Assay

Print article

Channels

Immunology

view channel
Image: Example image of the high-throughput microscopy method used in the study, showing immune cells stained with different fluorescence markers (Photo courtesy of Felix Kartnig/CeMM, MedUni Vienna)

Cutting-Edge Microscopy Technology Enables Tailored Rheumatology Therapies

Rheumatoid arthritis is the most common inflammatory joint disorder, with women three times as likely to suffer from the condition as men. Treatment advances made over the past decades have led to the... Read more

Microbiology

view channel
Image: RNA sequencing directly from whole blood aims to expand access to LRTI testing (Photo courtesy of CARB-X)

Novel Test to Diagnose Bacterial Pneumonia Directly from Whole Blood

Pneumonia and lower-respiratory-tract infections (LRTIs) are among the top causes of illness and death globally, particularly in vulnerable populations such as the elderly, young children, and immunocompromised... Read more

Pathology

view channel
Image: Lunit SCOPE HER2 is an AI-powered solution designed to detect HER2 expression profile (Photo courtesy of Lunit)

AI-Powered Pathology Solutions Accurately Predict Outcomes for HER2-Targeted Therapy in Metastatic CRC

A new study has highlighted how artificial intelligence (AI)-powered analysis of HER2 and the tumor microenvironment (TME) can improve patient stratification and predict clinical outcomes more effectively.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.